Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Oct 23, 2020
Technical advances towards the industrial application of transaminases for the synthesis of chiral amines
Read more
Scientific Article
Scientific Article
/ Jan 24, 2019
New crystalline forms of vilanterol trifenatate and processes for their preparation
Read more
Scientific Article